Title:
【発明の名称】HIV逆転写酵素阻害剤としての縮合ナフチリジン
Document Type and Number:
Japanese Patent JP2003512375
Kind Code:
A
Abstract:
The present invention relates to tricyclic compounds of formula (I): or stereoisomeric forms, stereoisomeric mixtures, or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of HIV reverse transcriptase, and to pharmaceutical compositions and diagnostic kits comprising the same, and methods of using the same for treating viral infection or as an assay standard or reagent.
Inventors:
Barry Elle Johnson
Mona Patel
James Dee Rogers
Hai Shen Wan
Christine M. Turby
Rajagopal Bhaxabad Shalam
Mona Patel
James Dee Rogers
Hai Shen Wan
Christine M. Turby
Rajagopal Bhaxabad Shalam
Application Number:
JP2001531836A
Publication Date:
April 02, 2003
Filing Date:
October 19, 2000
Export Citation:
Assignee:
DuPont Pharmaceuticals Company
International Classes:
A61K31/4375; A61K31/44; A61K31/496; A61K31/505; A61K31/519; A61K31/7072; A61K45/06; A61P31/18; A61P43/00; C07D471/04; C07D471/14; (IPC1-7): C07D471/04; A61K31/4375; A61K31/496; A61K31/519; A61K31/7072; A61P31/18; A61P43/00; C07D471/14
Attorney, Agent or Firm:
Yoshikazu Tani (2 outside)